The study, which was carried out by University of Texas researchers, has revealed that gangrene-causing bacteria can safely be used at high doses in patients with advanced cancers who fail to respond to other treatments.
This type of treatment is called bacterial therapy and has been shown to shrink and kill cancer cells.
These bacteria release spores which can be injected into tumors, causing necrosis and tumor cell death.
